Ingen internetforbindelse — viser den gemte version af siden.

Agios Pharm

USUSD
← Til screeneren

Agios Pharm (LSE:0HB0) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
agios.com
Investorrelationer
investor.agios.com/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
Cambridge, United States
Administrerende direktør
Brian M. Goff
Ansatte
539
Grundlagt
2008
Udestående aktier
59.7 mio. pr. 2026-07-24
Free float
50.02 mio.
Markedsværdi
2 mia. USD
Insidere
1.07%
Institutionelle investorer
112.31%
Branche (SIC)
Pharmaceutical Preparations
ISIN
US00847X1046
LEI
529900ONJHY8EOGYT555
FCF
−365 mio. USD
Gæld
0
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksAGIO primærUSD31.92 +0.41%almindelige aktier
LSE London Stock Exchange0HB0 IOBUSD33.1105 +0.00%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs
annonce

Største ejere

EjerAndelAktierRapportdato
Blackrock Inc.10.81%6.46 mio.2026-06-30
Farallon Capital Managem…9.91%5.92 mio.2026-06-30
State Street Corporation5.92%3.53 mio.2026-06-30
Lynx1 Capital Management…5.71%3.41 mio.2026-06-30
Shaw D.E. & Co., Inc.5.2%3.11 mio.2026-06-30
Vanguard Portfolio Manag…4.85%2.9 mio.2026-06-30
Vanguard Capital Managem…4.49%2.68 mio.2026-06-30
Armistice Capital, LLC4.02%2.4 mio.2026-06-30
Erste Asset Management G…3.61%2.15 mio.2026-06-30
SPDR SERIES TRUST-State…3.54%2.11 mio.2026-08-31
Nomura Asset Management…3.54%2.11 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.16%1.89 mio.2026-06-30
iShares Trust-iShares Ru…2.52%1.51 mio.2026-07-31
VANGUARD INDEX FUNDS-Van…2.28%1.36 mio.2026-06-30
Delaware Group Equity Fu…1.92%1.14 mio.2026-05-31
VANGUARD INDEX FUNDS-Van…1.32%788 6552026-06-30
VANGUARD INDEX FUNDS-Van…1.15%683 9902026-06-30
Fidelity Salem Street Tr…1.08%646 3182026-07-31
Fidelity Rutland Square…0.88%526 1212026-07-31
iShares Trust-iShares Ru…0.86%511 9942026-07-31
FOUSE JACQUALYN A. (Dire…≈0.26%154 1562026-06-18
GHEUENS SARAH (Officer)≈0.09%54 6452026-08-04
SCADDEN DAVID T. (Direct…≈0.03%20 4192026-06-18
HO MAYKIN (Director)≈0.03%19 8482026-06-18
BALLAL RAHUL D. (Directo…≈0.03%15 2302026-06-18
SMITH CYNTHIA (Director)≈0.03%15 2302026-06-18
FOSTER-CHEEK KAYE I (Dir…≈0.02%12 4842026-06-18
ADAMS CATHERINE OWEN (Di…≈0.02%10 8652026-06-18
CAPELLO JEFFREY D (Direc…≈0.02%10 8652026-06-18
BACKSTROM JAY T (Directo…≈0%1 4472026-07-08